Interius BioTherapeutics is based in Philadelphia, Country (or null). It has raised $76M in total funding. Latest round: Series A.
Interius BioTherapeutics is based in Philadelphia, Country (or null). Interius BioTherapeutics has raised $76M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in May 2021. The round record for Interius BioTherapeutics runs through 2021; nothing later has been disclosed. Investors on record include Cormorant Asset Management, Fairmount Funds, Bain Capital Life Sciences, Pfizer Ventures, RA Capital Management, Longwood Fund and 10 others. 16 distinct backers are named across the disclosed rounds.
Every Interius BioTherapeutics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Philadelphia at a similar stage.
Company funding database · Investor directory · Founder database · Mega-rounds 2026